Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,000 shares at $91.79 ($907K) on 2014-11-18, disclosed to the SEC on 2014-11-19.
Scheduled sale ($907k) by SVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.30 | 5,413 | $489K | 53.9% |
| 2 | $91.08 | 4,485 | $408K | 45.1% |
| 3 | $91.79 | 102 | $9K | 1.0% |
| Total | $90.67 avg | 10,000 | $907K | 100% |
| Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |
| ALNY | SELL | 2014-02-20 | $1.6M | — | Filing → |